Keep saving lives by prescribing methadone and buprenorphine. Learn how initiations of each have changed in the era of high-potency synthetic opioids (HPSOs) like fentanyl and how to continue to provide person-centered care to people with opioid use disorder. We’re joined by Dr Melissa Weimer, @DrMelissaWeimer (Yale University). This episode is in honor of National Addiction Treatment Week (treataddictionsavelives.org).
Claim CME for this episode at curbsiders.vcuhealth.org!
By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.
Episodes | Subscribe | Spotify | iTunes |
[email protected] | Free CME!
Credits
Producers: Shawn Cohen MD, Kenneth Morford MDWriter: Carolyn Chan MD MHSShow Notes: Shawn Cohen MDInfographic and Cover Art: Kenneth Morford MDHosts: Carolyn Chan MD. MHS Shawn Cohen MD, Natalie Stahl MD, Kenneth Morford MDReviewer: Kento Sonoda MDShowrunner: Carolyn Chan, MD, MHSTechnical Production: PodPasteGuest: Melissa Weimer DO MCR
Show Segments
Intro, disclaimer, guest bio 00:00Guest one-liner 05:02National Addiction Treatment Week 06:00Case from Kashlak; Definitions 08:30Starting methadone 11:01Common methadone pitfalls 15:00Buprenorphine precipitated opioid withdrawal 23:50High-dose buprenorphine 32:20Treating buprenorphine precipitated withdrawal 36:50Low-dose buprenorphine 41:50Maintenance dose of buprenorphine 48:15ER buprenorphine 49:00Take home points 53:31